CIBC World Markets’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-27,681
Closed -$1.77M 1715
2025
Q1
$1.77M Buy
27,681
+16,007
+137% +$930K 0.01% 527
2024
Q4
$558K Buy
+11,674
New +$599K ﹤0.01% 704
2021
Q2
Sell
-13,654
Closed -$569K 754
2021
Q1
$569K Buy
+13,654
New +$623K ﹤0.01% 774

Other funds holding HALO

CIBC World Markets's HALO Position: Q2 2025 in Review

CIBC World Markets sold out of Halozyme (HALO) in Q2 2025, closing a stake of 27,681 shares — an estimated $1.77M sold.

CIBC World Markets first reported a position in HALO in Q1 2021 and held it in 3 quarters. The position peaked at $1.77M in Q1 2025. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

  • CIBC World Markets reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
  • CIBC World Markets sold 27,681 Halozyme shares in Q2 2025, an estimated $1.77M.
  • CIBC World Markets first reported a position in Halozyme in Q1 2021 and held it in 3 quarters.
  • CIBC World Markets's Halozyme position peaked at $1.77M in Q1 2025.
  • 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.